Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Dec;52(5):611-22.
doi: 10.1097/QAI.0b013e3181b327ca.

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals

Affiliations
Meta-Analysis

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals

Meredith S Shiels et al. J Acquir Immune Defic Syndr. 2009 Dec.

Abstract

Objective: To estimate summary standardized incidence ratios (SIRs) of non-AIDS cancers among HIV-infected individuals compared with general population rates overall and stratified by gender, AIDS, and highly active antiretroviral therapy (HAART) era.

Design: A meta-analysis using SIRs from 18 studies of non-AIDS cancer in HIV-infected individuals.

Methods: SIRs for non-AIDS cancers in HIV-infected individuals and 95% confidence limits (CLs) were abstracted from each study. Random effects meta-analyses were used to estimate summary SIRs. Modifications by gender, AIDS, and HAART era were estimated with meta-regression.

Results: Four thousand seven hundred ninety-seven non-AIDS cancers occurred among 625,716 HIV-infected individuals. SIRs for several cancers were elevated. In particular, cancers associated with infections, such as anal (SIR = 28; 95% CL 21 to 35), liver (SIR = 5.6; 95% CL 4.0 to 7.7), and Hodgkin lymphoma (SIR = 11; 95% CL 8.8 to 15) and smoking, such as lung (SIR = 2.6; 95% CL 2.1 to 3.1), kidney (SIR = 1.7; 95% CL 1.3 to 2.2), and laryngeal (SIR = 1.5; 95% CL 1.1 to 2.0). AIDS was associated with greater SIRs for Hodgkin lymphoma, leukemia, lung, brain, and all non-AIDS cancers combined.

Conclusions: HIV-infected individuals may be at an increased risk of developing non-AIDS cancers, particularly those associated with infections and smoking. An association with advanced immune suppression was suggested for certain cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary standardized incidence ratios (SIRs) and 95% confidence limits for specific types of non-AIDS cancer, by gender.
  1. formula image Women

  2. formula image men

Figure 2
Figure 2
Summary standardized incidence ratios (SIRs) and 95% confidence limits for specific types of non-AIDS cancer, by AIDS status.
  1. formula image No AIDS

  2. formula image AIDS

Figure 3
Figure 3
Summary standardized incidence ratios (SIRs) and 95% confidence limits for specific types of non-AIDS cancer, by Highly Active Antiretroviral Therapy (HAART) era.
  1. formula image No HAART

  2. formula image HAART

References

    1. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962–972. - PubMed
    1. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR17):1–19. - PubMed
    1. Allardice GM, Hole DJ, Brewster DH, Boyd J, Goldberg DJ. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer. 2003;89(3):505–507. - PMC - PubMed
    1. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100(5):840–847. - PMC - PubMed
    1. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27(6):884–890. - PubMed

Publication types

Substances